TORONTO - Researchers at the University of Toronto's Joint Centre for Bioethics has determined 10 genomic and other biotechnologies that could significant impact global health within 10 years.
These include:
Technologies for environmental improvement (sanitation, clean water, bioremediation)
"Current inequities in global health present major ethical challenges to the international community<' says centre director Peter Singer, MD. "Genomics is described as a powerful new wave of health related life sciences energized by the human genome project. This study ranks the most promising tools being created by harnessing this knowledge, offering unprecedented opportunities to address the growing health divide between rich and poor countries."
For more information, visit: www.utoronto.ca/jcb/
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.